NYSEMKT: LCTX
Lineage Cell Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for LCTX

Based on 4 analysts offering 12 month price targets for Lineage Cell Therapeutics Inc

Min Forecast
$2.00+96.08%
Avg Forecast
$4.25+316.67%
Max Forecast
$9.00+782.35%

Should I buy or sell LCTX stock?

Based on 4 analysts offering ratings for Lineage Cell Therapeutics Inc.

Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although LCTX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates LCTX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their LCTX stock forecasts and price targets.

LCTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-23
lockedlocked$00.00+00.00%2025-06-23
lockedlocked$00.00+00.00%2025-03-14
lockedlocked$00.00+00.00%2025-01-10

1 of 1

LCTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LCTX$1.02$4.25+316.67%Strong Buy
CDXS$2.81N/AN/A
FENC$8.54$13.00+52.22%Buy
TVGN$1.25$10.00+700.00%Strong Buy
PRQR$2.13$8.14+282.30%Strong Buy

Lineage Cell Therapeutics Stock Forecast FAQ

Is Lineage Cell Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSEMKT: LCTX) stock is to Strong Buy LCTX stock.

Out of 4 analysts, 3 (75%) are recommending LCTX as a Strong Buy, 1 (25%) are recommending LCTX as a Buy, 0 (0%) are recommending LCTX as a Hold, 0 (0%) are recommending LCTX as a Sell, and 0 (0%) are recommending LCTX as a Strong Sell.

If you're new to stock investing, here's how to buy Lineage Cell Therapeutics stock.

What is LCTX's Price Target?

According to 4 Wall Street analysts that have issued a 1 year LCTX price target, the average LCTX price target is $4.25, with the highest LCTX stock price forecast at $9.00 and the lowest LCTX stock price forecast at $2.00.

On average, Wall Street analysts predict that Lineage Cell Therapeutics's share price could reach $4.25 by Jun 23, 2026. The average Lineage Cell Therapeutics stock price prediction forecasts a potential upside of 316.67% from the current LCTX share price of $1.02.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.